XERS Xeris Biopharma Holdings, Inc.
$6.63
▲ 4.08%
49
Value
19
P/E94.15
0
P/B86.89
0
P/S3.63
53
EV/EBITDA25.62
25
Growth
72
Revenue Growth43.7%
100
EPS Growth100.9%
50
FCF Growth173.8%
64
Momentum
64
12-Month Return54.2%
87
3-Month Return-4.1%
54
1-Month Return12.0%
75
RSI (14)57.14
64
50/200 MABearish
30
Profitability
53
ROE735.0%
100
ROA3.1%
31
Gross Margin59.4%
52
Operating Margin11.4%
37
Net Margin3.8%
32
FCF Yield5.0%
46
Risk
41
Beta0.92
90
60-Day Volatility46.4%
0
QScore Analysis